Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia
Clinical trial NCT05139095 · RECRUITING
Trial details
- NCT number
- NCT05139095
- Sponsor
- Peking Union Medical College Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-27
- Primary completion
- 2026-12-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.